HOME > VC DEALS > Kelonia Therapeutics, Inc.
Deal IconDeal

Kelonia Therapeutics, Inc.

Kelonia Therapeutics acquired by Lilly

Kelonia Therapeutics, Inc., a Boston-based in‑vivo CAR‑T biotech, was acquired for up to $7 billion by Eli Lilly and Company.

More on Crunchbase News →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs